Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wilding

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2004
AOD-9604 MetabolicJohn Wilding
BMJ (Clinical Research Ed.)|May 2, 2013
Orlistat: should we worry about liver inflammation?John Wilding
Current Drug Targets|April 3, 2004
Clinical evaluation of anti-obesity drugsJohn Wilding
BMJ (Clinical Research Ed.)|September 13, 2012
Are the causes of obesity primarily environmental? YesJohn Wilding
Nature Reviews. Endocrinology|October 24, 2019
SGLT2 inhibitors and urinary tract infectionsJohn Wilding
The Lancet. Diabetes & Endocrinology|March 25, 2016
SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?John Wilding
The Practitioner|March 3, 2015
Managing patients with type 2 diabetes and obesityJohn Wilding
Nature Medicine|October 16, 2020
Weight loss is the major player in bariatric surgery benefitsJohn Wilding
The British Journal of Developmental Psychology|January 11, 2011
Is attention impaired in ADHD?John Wilding
The British Journal of Developmental Psychology|January 11, 2011
Measuring attentionJohn Wilding
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2004
AOD-9604 MetabolicJohn Wilding
BMJ (Clinical Research Ed.)|May 2, 2013
Orlistat: should we worry about liver inflammation?John Wilding
Current Drug Targets|April 3, 2004
Clinical evaluation of anti-obesity drugsJohn Wilding
BMJ (Clinical Research Ed.)|September 13, 2012
Are the causes of obesity primarily environmental? YesJohn Wilding
Nature Reviews. Endocrinology|October 24, 2019
SGLT2 inhibitors and urinary tract infectionsJohn Wilding
The Lancet. Diabetes & Endocrinology|March 25, 2016
SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?John Wilding
The Practitioner|March 3, 2015
Managing patients with type 2 diabetes and obesityJohn Wilding
Nature Medicine|October 16, 2020
Weight loss is the major player in bariatric surgery benefitsJohn Wilding
The British Journal of Developmental Psychology|January 11, 2011
Is attention impaired in ADHD?John Wilding
The British Journal of Developmental Psychology|January 11, 2011
Measuring attentionJohn Wilding
Pageof 8